911
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Factors affecting the primary patency of native arteriovenous fistulas after ultrasound-guided percutaneous transluminal angioplasty

, , , , , , & ORCID Icon show all
Article: 2233623 | Received 03 Feb 2023, Accepted 30 Jun 2023, Published online: 24 Jul 2023

References

  • Woodside KJ, Bell S, Mukhopadhyay P, et al. Arteriovenous fistula maturation in prevalent hemodialysis patients in the United States: a national study. Am J Kidney Dis. 2018;71(6):1–9. doi: 10.1053/j.ajkd.2017.11.020.
  • Riella MC, Roy-Chaudhury P. Vascular access in haemodialysis: strengthening the Achilles’ heel. Nat Rev Nephrol. 2013;9(6):348–357. doi: 10.1038/nrneph.2013.76.
  • Hakim R, Himmelfarb J. Hemodialysis access failure: a call to action. Kidney Int. 1998;54(4):1029–1040. doi: 10.1046/j.1523-1755.1998.00122.x.
  • Long B, Brichart N, Lermusiaux P, et al. Management of perianastomotic stenosis of direct wrist autogenous radial-cephalic arteriovenous accesses for dialysis. J Vasc Surg. 2011;53(1):108–114. doi: 10.1016/j.jvs.2010.08.007.
  • Schmidli J, Widmer MK, Basile C, et al., Editor’s choice – vascular access: 2018 clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55(6):757–818. doi: 10.1016/j.ejvs.2018.02.001.
  • Nalesso F, Garzotto F, Petrucci I, et al. Standardized protocol for hemodialysis vascular access assessment: the role of ultrasound and color Doppler. Blood Purif. 2018;45(1–3):260–269. doi: 10.1159/000485590.
  • Napoli M, Bacchini G, Scarpati L, et al. Ultrasound guided interventional procedures on arteriovenous fistulae. J Vasc Access. 2021;22(1 Suppl.):91–96. doi: 10.1177/1129729820977380.
  • Sofocleous CT, Schur I, Koh E, et al. Percutaneous treatment of complications occurring during hemodialysis graft recanalization. Eur J Radiol. 2003;47(3):237–246. doi: 10.1016/s0720-048x(02)00087-6.
  • Turmel-Rodrigues L, Pengloan J, Bourquelot P. Interventional radiology in hemodialysis fistulae and grafts: a multidisciplinary approach. Cardiovasc Intervent Radiol. 2002;25(1):3–16. doi: 10.1007/s00270-001-0082-y.
  • Flu H, Breslau PJ, Krol-van Straaten JM, et al. The effect of implementation of an optimized care protocol on the outcome of arteriovenous hemodialysis access surgery. J Vasc Surg. 2008;48(3):659–668. doi: 10.1016/j.jvs.2008.04.002.
  • Greenberg JI, Suliman A, Angle N. Endovascular dialysis interventions in the era of DOQI. Ann Vasc Surg. 2008;22(5):657–662. doi: 10.1016/j.avsg.2008.03.006.
  • Neuen BL, Gunnarsson R, Baer RA, et al. Factors associated with patency following angioplasty of hemodialysis fistulae. J Vasc Interv Radiol. 2014;25(9):1419–1426. doi: 10.1016/j.jvir.2014.05.020.
  • Higashiura W, Takara H, Kitamura R, et al. Factors associated with secondary functional patency after percutaneous transluminal angioplasty of the early failing or immature hemodialysis arteriovenous fistula. Cardiovasc Intervent Radiol. 2019;42(1):34–40. doi: 10.1007/s00270-018-2083-0.
  • Bautista AB, Suhocki PV, Pabon-Ramos WM, et al. Postintervention patency rates and predictors of patency after percutaneous interventions on intragraft stenoses within failing prosthetic arteriovenous grafts. J Vasc Interv Radiol. 2015;26(11):1673–1679. doi: 10.1016/j.jvir.2015.08.008.
  • Leskovar B, Furlan T, Poznič S, et al. Ultrasound-guided percutaneous endovascular treatment of arteriovenous fistula/graft. Clin Nephrol. 2017;88(13):61–64. doi: 10.5414/CNP88FX15.
  • Granata A, Maccarrone R, Di Lullo L, et al. Feasibility of routine ultrasound-guided percutaneous transluminal angioplasty in the treatment of native arteriovenous fistula dysfunction. J Vasc Access. 2021;22(5):739–743. doi: 10.1177/1129729820943076.
  • Wakabayashi M, Hanada S, Nakano H, et al. Ultrasound-guided endovascular treatment for vascular access malfunction: results in 4896 cases. J Vasc Access. 2013;14(3):225–230. doi: 10.5301/jva.5000126.
  • Cho S, Lee YJ, Kim SR. Clinical experience with ultrasound guided angioplasty for vascular access. Kidney Res Clin Pract. 2017;36(1):79–85. doi: 10.23876/j.krcp.2017.36.1.79.
  • Bacchini G, Cappello A, La Milia V, et al. Color Doppler ultrasonography imaging to guide transluminal angioplasty of venous stenosis. Kidney Int. 2000;58(4):1810–1813. doi: 10.1046/j.1523-1755.2000.00344.x.
  • Yap Y-S, Chi W-C, Lin C-H, et al. Factors affecting patency of arteriovenous fistula following first percutaneous transluminal angioplasty. Clin Exp Nephrol. 2021;25(1):80–86. doi: 10.1007/s10157-020-01958-w.
  • Neuen BL, Gunnarsson R, Webster AC, et al. Predictors of patency after balloon angioplasty in hemodialysis fistulas: a systematic review. J Vasc Interv Radiol. 2014;25(6):917–924. doi: 10.1016/j.jvir.2014.02.010.
  • Chen L, Zhang W, Tan J, et al. Morphological lesion types are associated with primary and secondary patency rates after high-pressure balloon angioplasty for dysfunctional arteriovenous fistulas. Blood Purif. 2022;51(5):425–434. doi: 10.1159/000516883.
  • Sidawy AN, Gray R, Besarab A, et al. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg. 2002;35(3):603–610. doi: 10.1067/mva.2002.122025.
  • Aruny JE, Lewis CA, Cardella JF, et al. Quality improvement guidelines for percutaneous management of the thrombosed or dysfunctional dialysis access. J Vasc Interv Radiol. 1999;10(4):491–498. doi: 10.1016/s1051-0443(99)70071-0.
  • Campos RP, Do Nascimento MM, Chula DC, et al. Stenosis in hemodialysis arteriovenous fistula: evaluation and treatment. Hemodial Int. 2006;10(2):152–161. doi: 10.1111/j.1542-4758.2006.00087.x.
  • Stolic R. Most important chronic complications of arteriovenous fistulas for hemodialysis. Med Princ Pract. 2013;22(3):220–228. doi: 10.1159/000343669.
  • Wen M, Li Z, Li J, et al. Risk factors for primary arteriovenous fistula dysfunction in hemodialysis patients: a retrospective survival analysis in multiple medical centers. Blood Purif. 2019;48(3):276–282. doi: 10.1159/000500045.
  • Wu C-C, Wen S-C, Yang C-W, et al. Baseline plasma glycemic profiles but not inflammatory biomarkers predict symptomatic restenosis after angioplasty of arteriovenous fistulas in patients with hemodialysis. Atherosclerosis. 2010;209(2):598–600. doi: 10.1016/j.atherosclerosis.2009.10.021.
  • Lin SL, Huang CH, Chen HS, et al. Effects of age and diabetes on blood flow rate and primary outcome of newly created hemodialysis arteriovenous fistulas. Am J Nephrol. 1998;18(2):96–100. doi: 10.1159/000013315.
  • Huijbregts HJT, Bots ML, Wittens CHA, et al. Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol. 2008;3(3):714–719. doi: 10.2215/CJN.02950707.
  • Afsar B, Elsurer R. The primary arteriovenous fistula failure-a comparison between diabetic and non-diabetic patients: glycemic control matters. Int Urol Nephrol. 2012;44(2):575–581. doi: 10.1007/s11255-011-9978-x.
  • Heye S, Maleux G, Vaninbroukx J, et al. Factors influencing technical success and outcome of percutaneous balloon angioplasty in de novo native hemodialysis arteriovenous fistulas. Eur J Radiol. 2012;81(9):2298–2303. doi: 10.1016/j.ejrad.2011.09.004.
  • London GM, Guérin AP, Marchais SJ, et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18(9):1731–1740. doi: 10.1093/ndt/gfg414.
  • Torres PA, De Broe M. Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease. Kidney Int. 2012;82(1):19–25. doi: 10.1038/ki.2012.69.
  • Cozzolino M, Gallieni M, Brancaccio D. The mechanisms of hyperphosphatemia-induced vascular calcification. Int J Artif Organs. 2008;31(12):1002–1003. doi: 10.1177/039139880803101203.
  • Lyu B, Banerjee T, Scialla JJ, et al. Vascular calcification markers and hemodialysis vascular access complications. Am J Nephrol. 2018;48(5):330–338. doi: 10.1159/000493549.
  • Malluche HH, Blomquist G, Monier-Faugere M-C, et al. High parathyroid hormone level and osteoporosis predict progression of coronary artery calcification in patients on dialysis. J Am Soc Nephrol. 2015;26(10):2534–2544. doi: 10.1681/ASN.2014070686.
  • Chertow GM, Burke SK, Raggi P, et al. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002;62(1):245–252. doi: 10.1046/j.1523-1755.2002.00434.x.
  • Chertow GM, Raggi P, Chasan-Taber S, et al. Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant. 2004;19(6):1489–1496. doi: 10.1093/ndt/gfh125.
  • Nakao Y, Koike T, Ohta Y, et al. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3′, 5′-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells. Bone. 2009;44(5):872–877. doi: 10.1016/j.bone.2009.01.370.
  • Cheng Z-Y, Ye T, Ling Q-Y, et al. Parathyroid hormone promotes osteoblastic differentiation of endothelial cells via the extracellular signal-regulated protein kinase 1/2 and nuclear factor-kappaB signaling pathways. Exp Ther Med. 2018;15(2):1754–1760. doi: 10.3892/etm.2017.5545.
  • Peng AW, Dardari ZA, Blumenthal RS, et al. Very high coronary artery calcium (>/=1000) and association with cardiovascular disease events, non-cardiovascular disease outcomes, and mortality: results from MESA. Circulation. 2021;143(16):1571–1583. doi: 10.1161/CIRCULATIONAHA.120.050545.
  • Romann A, Beaulieu MC, Rhéaume P, et al. Risk factors associated with arteriovenous fistula failure after first radiologic intervention. J Vasc Access. 2016;17(2):167–174. doi: 10.5301/jva.5000459.